20 April 2026: QScint announces installation of iQID NSight Medium radionuclide imager at the Center for Addiction and Mental Health (CAMH)
Toronto, Canada and Tucson, AZ - April 20, 2026 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative radionuclide imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced the installation of its iQID NSight Medium particle imager at the Center for Addiction and Mental Health (CAMH) in Toronto.
“This iQID will see major use for imaging tritium in the research program at CAMH. We’re thrilled to help CAMH get faster, higher-resolution images of this important radionuclide than was possible with their previous phosphor-screen-based workflow” commented Dr. Brian Miller, President of QScint on the install.
